Skip to main content

. 1980 Dec;56(6):414–415. doi: 10.1136/sti.56.6.414-b

Treatment of lymphogranuloma venereum with rifampicin.

PMCID: PMC1045847 PMID: 6778590

414

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Acocella G., Hamilton-Miller J. M., Brumfitt W. Can rifampicin use be safely extended? Evidence for non-emergence of resistant strains of Mycobacterium tuberculosis. Lancet. 1977 Apr 2;1(8014):740–742. doi: 10.1016/s0140-6736(77)92179-1. [DOI] [PubMed] [Google Scholar]
Girling D. J. Adverse reactions to rifampicin in antituberculosis regimens. J Antimicrob Chemother. 1977 Mar;3(2):115–132. doi: 10.1093/jac/3.2.115. [DOI] [PubMed] [Google Scholar]
Menke H. E., Schuller J. L., Stolz E., Niemel P. L., Michel M. F. Treatment of lymphogranuloma venereum with rifampicin. Br J Vener Dis. 1979 Oct;55(5):379–379. doi: 10.1136/sti.55.5.379. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES